92 related articles for article (PubMed ID: 16647709)
1. Inhibition of vacuolar-type (H+)-ATPase by the cytostatic macrolide apicularen A and its role in apicularen A-induced apoptosis in RAW 264.7 cells.
Hong J; Yokomakura A; Nakano Y; Ishihara K; Kaneda M; Onodera M; Nakahama K; Morita I; Niikura K; Ahn JW; Zee O; Ohuchi K
FEBS Lett; 2006 May; 580(11):2723-30. PubMed ID: 16647709
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of bone resorption in cultures of mouse calvariae by apicularen A.
Hong J; Sasaki H; Niikura K; Yanai M; Nakano Y; Yokomakura A; Ishihara K; Hirasawa N; Kang YS; Oh JS; Kwak JH; Zee O; Ohuchi K
Planta Med; 2007 Feb; 73(2):173-5. PubMed ID: 17415879
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis of RAW 264.7 cells by the cytostatic macrolide apicularen A.
Hong J; Yamaki K; Ishihara K; Ahn JW; Zee O; Ohuchi K
J Pharm Pharmacol; 2003 Sep; 55(9):1299-306. PubMed ID: 14604474
[TBL] [Abstract][Full Text] [Related]
4. Archazolid and apicularen: novel specific V-ATPase inhibitors.
Huss M; Sasse F; Kunze B; Jansen R; Steinmetz H; Ingenhorst G; Zeeck A; Wieczorek H
BMC Biochem; 2005 Aug; 6():13. PubMed ID: 16080788
[TBL] [Abstract][Full Text] [Related]
5. Induction of nitric oxide production by the cytostatic macrolide apicularen A [2,4-heptadienamide, N-[(1E)-3-[(3S,5R,7R,9S)-3,4,5,6,7,8,9,10-octahydro-7,14 dihydroxy-1-oxo-5,9-epoxy-1H-2-benzoxacyclododecin-3-yl]-1 propenyl]-, (2Z,4Z)-(9CI)] and possible role of nitric oxide in apicularen A-induced apoptosis in RAW 264.7 cells.
Hong J; Yokomakura A; Nakano Y; Ban HS; Ishihara K; Ahn JW; Zee O; Ohuchi K
J Pharmacol Exp Ther; 2005 Mar; 312(3):968-77. PubMed ID: 15561798
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by apicularen A in human promyelocytic leukemia cell line HL-60.
Hong J; Ishihara K; Zee O; Ohuchi K
Planta Med; 2005 Apr; 71(4):306-12. PubMed ID: 15856405
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
[TBL] [Abstract][Full Text] [Related]
8. The binding site of the V-ATPase inhibitor apicularen is in the vicinity of those for bafilomycin and archazolid.
Osteresch C; Bender T; Grond S; von Zezschwitz P; Kunze B; Jansen R; Huss M; Wieczorek H
J Biol Chem; 2012 Sep; 287(38):31866-76. PubMed ID: 22815478
[TBL] [Abstract][Full Text] [Related]
9. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase.
Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C
J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological characterization of ATPases in native synaptic vesicles and synaptic plasma membranes.
Obrdlik P; Diekert K; Watzke N; Keipert C; Pehl U; Brosch C; Boehm N; Bick I; Ruitenberg M; Volknandt W; Kelety B
Biochem J; 2010 Mar; 427(1):151-9. PubMed ID: 20100168
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and structure activity relationships of bafilomycin A1, a potent and selective inhibitor of the vacuolar H+-ATPase.
Gagliardi S; Rees M; Farina C
Curr Med Chem; 1999 Dec; 6(12):1197-212. PubMed ID: 10519916
[TBL] [Abstract][Full Text] [Related]
13. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1.
Ohta T; Arakawa H; Futagami F; Fushida S; Kitagawa H; Kayahara M; Nagakawa T; Miwa K; Kurashima K; Numata M; Kitamura Y; Terada T; Ohkuma S
J Pathol; 1998 Jul; 185(3):324-30. PubMed ID: 9771488
[TBL] [Abstract][Full Text] [Related]
14. H+-ATPase of crude homogenate of the outer mantle epithelium of Anodonta cygnea.
Oliveira PF; Lopes IA; Barrias C; Rebelo da Costa AM
Comp Biochem Physiol A Mol Integr Physiol; 2004 Dec; 139(4):425-32. PubMed ID: 15596387
[TBL] [Abstract][Full Text] [Related]
15. The vacuolar H+-ATPase of lemon fruits is regulated by variable H+/ATP coupling and slip.
Müller ML; Jensen M; Taiz L
J Biol Chem; 1999 Apr; 274(16):10706-16. PubMed ID: 10196141
[TBL] [Abstract][Full Text] [Related]
16. pH dependence and inhibition by extracellular calcium of proton currents via plasmalemmal vacuolar-type H+-ATPase in murine osteoclasts.
Sakai H; Kawawaki J; Moriura Y; Mori H; Morihata H; Kuno M
J Physiol; 2006 Oct; 576(Pt 2):417-25. PubMed ID: 16901940
[TBL] [Abstract][Full Text] [Related]
17. 5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity.
Gagliardi S; Nadler G; Consolandi E; Parini C; Morvan M; Legave MN; Belfiore P; Zocchetti A; Clarke GD; James I; Nambi P; Gowen M; Farina C
J Med Chem; 1998 May; 41(10):1568-73. PubMed ID: 9572882
[TBL] [Abstract][Full Text] [Related]
18. V-ATPase inhibitors and implication in cancer treatment.
Pérez-Sayáns M; Somoza-Martín JM; Barros-Angueira F; Rey JM; García-García A
Cancer Treat Rev; 2009 Dec; 35(8):707-13. PubMed ID: 19758758
[TBL] [Abstract][Full Text] [Related]
19. Destruxin B, a specific and readily reversible inhibitor of vacuolar-type H(+)-translocating ATPase.
Muroi M; Shiragami N; Takatsuki A
Biochem Biophys Res Commun; 1994 Dec; 205(2):1358-65. PubMed ID: 7802670
[TBL] [Abstract][Full Text] [Related]
20. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor.
Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T
Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
